These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35799080)

  • 1. Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic.
    Velez FF; Anastassopoulos KP; Colman S; Shah N; Kauffman L; Murphy SM; Ruetsch C; Maricich YA
    Adv Ther; 2022 Sep; 39(9):4131-4145. PubMed ID: 35799080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic.
    Shah N; Velez FF; Colman S; Kauffman L; Ruetsch C; Anastassopoulos K; Maricich Y
    Adv Ther; 2022 Sep; 39(9):4146-4156. PubMed ID: 35819569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic.
    Velez FF; Colman S; Kauffman L; Ruetsch C; Anastassopoulos K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Feb; 21(1):69-76. PubMed ID: 33146558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder.
    Velez FF; Colman S; Kauffman L; Ruetsch C; Anastassopoulos K; Maricich YA
    Clinicoecon Outcomes Res; 2021; 13():909-916. PubMed ID: 34754205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-world changes in US health system hospital-based services following treatment with a prescription digital therapeutic for opioid use disorder.
    Velez FF; Colman S; Kauffman L; Anastassopoulos K; Murphy S; Maricich Y
    Hosp Pract (1995); 2021 Dec; 49(5):341-347. PubMed ID: 34275401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic modeling of reSET-O, a prescription digital therapeutic for patients with opioid use disorder.
    Wang W; Gellings Lowe N; Jalali A; Murphy SM
    J Med Econ; 2021; 24(1):61-68. PubMed ID: 33267633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder.
    Velez FF; Huang D; Mody L; Malone DC
    Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):599-607. PubMed ID: 34894988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world use and clinical outcomes after 24 weeks of treatment with a prescription digital therapeutic for opioid use disorder.
    Maricich YA; Gerwien R; Kuo A; Malone DC; Velez FF
    Hosp Pract (1995); 2021 Dec; 49(5):348-355. PubMed ID: 34461801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world evidence for a prescription digital therapeutic to treat opioid use disorder.
    Maricich YA; Xiong X; Gerwien R; Kuo A; Velez F; Imbert B; Boyer K; Luderer HF; Braun S; Williams K
    Curr Med Res Opin; 2021 Feb; 37(2):175-183. PubMed ID: 33140981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prescription Digital Therapeutic to Support Unsupervised Buprenorphine Initiation for Patients With Opioid Use Disorder: Protocol for a Proof-of-Concept Study.
    Luderer H; Enman N; Gerwien R; Braun S; McStocker S; Xiong X; Koebele C; Cannon C; Glass J; Maricich Y
    JMIR Res Protoc; 2023 Jan; 12():e43122. PubMed ID: 36662568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Hospital Adoption of an Emergency Department Treatment Pathway for Opioid Use Disorder and Patient Initiation of Buprenorphine After Discharge.
    Solomon KT; O'Connor J; Gibbons JB; Kilaru AS; Feder KA; Xue L; Saloner B; Stuart EA; Cole ES; Hulsey E; Meisel Z; Patel E; Donohue JM
    JAMA Health Forum; 2023 Mar; 4(3):e230245. PubMed ID: 36961457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the cost-utility of a prescription digital therapeutic for the treatment of opioid use disorder.
    Velez FF; Luderer HF; Gerwien R; Parcher B; Mezzio D; Malone DC
    Postgrad Med; 2021 May; 133(4):421-427. PubMed ID: 33593201
    [No Abstract]   [Full Text] [Related]  

  • 13. Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data.
    Choong CK; Ford JH; Nyhuis AW; Robinson RL; Aurora SK
    J Manag Care Spec Pharm; 2018 Sep; 24(9):921-928. PubMed ID: 30156448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare Use After Buprenorphine Prescription in a Community Emergency Department: A Cohort Study.
    Le T; Cordial P; Sankoe M; Purnode C; Parekh A; Baker T; Hiestand B; Peacock WF; Neuenschwander J
    West J Emerg Med; 2021 Sep; 22(6):1270-1275. PubMed ID: 34787550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
    Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
    Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of a prescription digital therapeutic as an adjunct to buprenorphine for treatment of opioid use disorder.
    Maricich YA; Bickel WK; Marsch LA; Gatchalian K; Botbyl J; Luderer HF
    Curr Med Res Opin; 2021 Feb; 37(2):167-173. PubMed ID: 33140994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in healthcare utilization and associated costs between patients prescribed vs. nonprescribed opioids during an inpatient or emergency department visit.
    Xie L; Joshi AV; Schaaf D; Mardekian J; Harnett J; Shah ND; Baser O
    Pain Pract; 2014 Jun; 14(5):446-56. PubMed ID: 23809064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of an emergency department peer navigator (EDPN) program in improving clinical outcomes and healthcare utilization in an urban setting.
    Santos C; Ramdin C; Becceril J; Al Kik B; Jefri M; Nelson L
    Am J Emerg Med; 2023 Jun; 68():10-16. PubMed ID: 36905880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
    Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
    Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness Analysis of a Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder.
    Velez FF; Malone DC
    J Mark Access Health Policy; 2021; 9(1):1966187. PubMed ID: 34434535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.